Login | Join Our Mailing List | Site Map | Contact Us  twitter linkedin flickr email blog
Search
Welcome to The Food and Drug Law Institute FDLI Logo About FDLIMembershipConferencesPublicationsProfessional Services DirectoryAcademicHome


General

Vision, Mission
and Values

Privacy Policy

Board of Directors

Committees

FDLI Staff

Distinguished Service & Leadership Award

Location

Press Releases

Job Board


bottom bar

FDLI COMMITTEES

As a membership organization, the Food and Drug Law Institute depends on the dedication and commitment of its members to enhance association programs.

FDLI committees consist of volunteer members who provide expertise regarding Institute programming, publications and activities.

If you are a member in good standing and would like to inquire about joining a committee
please contact FDLI to learn more.

Academic Programs Committee


The Academic Programs Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the academic legal community. The Committee discusses various programs, publications, pricing, dissemination vehicles, etc. that best facilitate expanding FDLI's educational mission.

Wade Ackerman, FDA - OC

Richard H. Alpert, Suffolk University Law School

Patricia L. Farnese, BA, LLM, University of Saskatchewan

Deborah Flint, Sole Practitioner

Ralph F. Hall, University of Minnesota

Eleanor D. Kinney, Indiana University School of Law - Indianapolis

Areta L. Kupchyk, Nixon Peabody LLP

Annemarie Martin-Boyan, Sole Practitioner

Peter R. Mathers, Kleinfeld, Kaplan & Becker, LLP

Margaret Sova McCabe, University of New Hampshire School of Law

Christine E. Mulshine, Children's Medical Center-Ambulatory Care Pavilion

Francis B. Palumbo, PhD, University of Maryland School of Pharmacy
Chair

Bruce Patsner, MD, JD, University of Houston

Perry W. Payne, MD, JD, George Washington University

Ross H. Pifer, Penn State Dickinson School of Law

R. William Soller, PhD, University of California-San Francisco

Victoria Sutton, PhD, JD, Texas Tech University

Jordan K. Paradise, Seton Hall University School of Law
Vice Chair

Audit Committee

Karen M. Becker, PhD, IndigoBay Ventures, LLC

Michael N. Druckman, Hogan Lovells LLP

Sheila M. Hemeon-Heyer, Heyer Regulatory Solutions LLC
Chair

William H. Kitchens, Arnall Golden Gregory LLP

Scott M. Lassman, Kleinfeld, Kaplan & Becker, LLP

Austern Writing Awards Committee - Long Papers

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

Nathan J. Bailey, Greenblum & Bernstein, P.L.C.

Maya P. Florence, Skadden, Arps, Slate, Meagher & Flom LLP

William A. Garvin, Buchanan Ingersoll & Rooney PC

David M. Gryte, AstraZeneca Pharmaceuticals

Christine E. Mulshine, Children's Medical Center-Ambulatory Care Pavilion
Chair

Joseph A. Page, Georgetown University

Jolyda S. Swaim, Olsson Frank Weeda Terman Matz PC

Gregory Wartman, Esq., Saul Ewing LLP

Raqiyyah R. Pippins, Kelley Drye & Warren LLP
Vice Chair

Austern Writing Awards Committee - Short Papers

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

Alena M. Allen, University of Memphis

Carlos T. Angulo, Zuckerman Spaeder LLP

James M. Flaherty, Jr., Foley Hoag LLP

Elizabeth F. Gluck, King & Spalding LLP

Paula Katz, FDA - CDER

Matthew R. Kyle, Millennium Medical Technologies, Inc.

Peter R. Mathers, Kleinfeld, Kaplan & Becker, LLP
Chair

Shannon G. May, Sole Practitioner

Danielle C. Woodlee, Hogan Lovells LLP
Vice Chair

Board of Directors

Elizabeth H. Anderson, Personal Care Products Council

Frederick R. Ball, Duane Morris LLP

Robert E. Brackett, PhD, Institute for Food Safety and Health at Illinois Institute of Technology

Sheila M. Hemeon-Heyer, Heyer Regulatory Solutions LLC

Kay Holcombe, Genzyme Corporation

Philip Katz, Hogan Lovells LLP

Geoffrey M. Levitt, Pfizer, Inc.
Chair

Erika F. Lietzan, Covington & Burling LLP

Daniel F. Shaw, H.J. Heinz Company

Elizabeth H. Anderson, Personal Care Products Council
Vice Chair

Minnie V. Baylor-Henry, JD, Johnson & Johnson
Immediate Past Chair

Jeffrey N. Gibbs, Hyman, Phelps & McNamara, P.C.
Secretary and General Counsel

Susan C. Winckler, RPh, JD, FDLI
President & CEO

Drugs and Biologics Committee


The Drugs and Biologics Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the drugs and biologics industries. The Committee advises staff on the appropriateness of conferences and publications relating to pharmaceuticals and biologics by reviewing and commenting on proposals.

David G. Adams, Venable, LLP

Deborah M. Autor, JD, FDA - OC
Co-Chair

Virginia G. Beakes-Read, JD, Eisai Inc.

Edward Berg, Sanofi-Aventis

Cathy L. Burgess, Alston & Bird LLP

Jordan D. Cooper, Cephalon, Inc.

Sandra J.P. Dennis, Biotechnology Industry Organization

Paul T. Kim, Foley Hoag LLP

Patricia Knight, FoxKiser

Daniel A. Kracov, Arnold & Porter LLP
Co-Chair

Chad A. Landmon, Axinn, Veltrop & Harkrider LLP

Matthew M. Malloy, The Procter & Gamble Company

Daniel Meron, Latham & Watkins LLP

Sandra Milligan, Amgen Inc.

Ann K. Rosen, GlaxoSmithKline

Douglas L. Sporn, D Sporn Consulting LLC

Roy J. Sturgeon, PhD, Lachman Consultants

Deborah E. Tolomeo, Genentech, Inc.

Sharon A. Tonetta, Ph.D., Bausch & Lomb, Incorporated

Editorial Advisory Board (Journal)

The Journal Editorial Advisory Board promotes the educational, scholarly, and other purposes of the Food and Drug Law Journal. Members of the Board serve as peer reviewers for papers submitted for publication and recommend topics for "special / symposia" issues.

Judith E. Beach, Quintiles Transnational Corporation

Tracy P. Berns, Covidien

Esther Bleicher, FDA - OC

Christine P. Bump, Goodwin Procter LLP

Azim Chowdhury, Keller and Heckman LLP

Jeffrey K. Francer, PhRMA

Michael M. Gaba, Holland & Knight LLP

Ilene Ringel Heller, Venable, LLP

Devon Hill, Keller and Heckman LLP

Joel E. Hoffman, George Mason University

Jeremiah J. Kelly, US Army

Kyle Lathrop, W.L. Gore and Associates

Rachel G. Lattimore, Arent Fox LLP

Laurie Lenkel, FDA - OC
Chair

Natasha V. Leskovsek, Cooley LLP

Joy Liu, Ropes & Gray LLP

Deborah Livornese, FDA - CDER

Christopher-Paul Milne, PhD, MPH, Tufts University

Jennifer Newberger, Hyman, Phelps & McNamara, P.C.

Maura Martin Norden, Sidley Austin LLP

James T. O'Reilly, University of Cincinnati

Kelly N. Reeves, King & Spalding LLP

Joan R. Rothenberg, FDA - ORA

Jeffrey M. Senger, Sidley Austin LLP

Krista Hessler Carver, Covington & Burling LLP
First Vice Chair

Carlos Celestino, JD, U.S. Pharmacopeia
Second Vice Chair

Editorial Advisory Board (Monographs)

Ricardo Carvajal, Hyman, Phelps & McNamara, P.C.

Alice Valder Curran, Hogan Lovells LLP
Chair

Joanne Hawana, Arent Fox LLP

Eric David Kupferberg, PhD, Northeastern University

Mark C. Levy, Eckert Seamans Cherin & Mellott, LLC

Brian J. Malkin, Frommer Lawrence & Haug LLP

Benjamin S. Martin, Epstein Becker & Green, P.C.

Lance L. Shea, MS, Fulbright & Jaworski L.L.P.

Marta L. Villarraga, PhD, Exponent, Inc.

Scott D. Danzis, Covington & Burling LLP
Vice Chair

Editorial Advisory Board (Policy Forum)

Christina L. Anderson, Medtronic, Inc.

Peggy Armstrong, International Dairy Foods Association

Marice Ashe, Public Health Law and Policy

Brendan Benner, Medical Device Manufacturers Association

James E. Dillard, III, Altria Client Services, Inc.

Sandra B. Eskin, Esq., The Pew Charitable Trusts

Eric Feldman, University of Pennsylvania

Paul A. Franz, The Procter & Gamble Company

Lawrence O. Gostin, J.D., Georgetown University

Robert L. Guenther, United Fresh Produce Association

Carolina Heavner, K&L Gates LLP

Mary Clare Kimber, Plasma Protein Therapeutics Association

Patricia A. Maloney, Quest Diagnostics

Gary C. Messplay, Hunton & Williams LLP

Mark Pollak, Personal Care Products Council

Lori M. Reilly, PhRMA

Timothy W. Schmidt, Johnson Controls

David C. Spangler, Esq., Consumer Healthcare Products Association (CHPA)

William W. Vodra, Arnold & Porter LLP
Chair

Sheila D. Walcoff, Goldbug Strategies LLC

Pamela Wilger, Cargill, Inc.

Lisa Ann Zoks, Drug Information Association

Joseph L. Fink III, University of Kentucky
Vice Chair

Elizabeth H. Anderson, Personal Care Products Council
Board Liaison

Editorial Advisory Board (Update)

The Update Editorial Advisory Board promotes the highest levels of professional, educational, and scholarly written commentary on timely issues of interest to professionals in the areas of foods, drugs, biologics, medical devices, other healthcare technologies, and cosmetics in FDLI's magazine The Board serves as a resource for FDLI staff to develop feature theme ideas, acquire articles of interest to readers, and advise on the magazine's quality and success in serving the interests and needs of its readers.

Frederick R. Ball, Duane Morris LLP

Barry A. Berger, Temple University

Joanna T. Brougher, Harvard School of Public Health

Michele L. Buenafe, Morgan, Lewis & Bockius LLP

Daniel P. Carmichael, Faegre Baker Daniels LLP

Megan Clark, FDA - OC
Chair

Carrie Dooher, Esq., Sole Practitioner

Elizabeth Barr Fawell, Hogan Lovells LLP

Suchira Ghosh, Axinn, Veltrop & Harkrider LLP

Naomi J.L. Halpern, Arent Fox LLP

Mari Mansfield, Quintiles

Rikin S. Mehta, PharmD, JD, FDA - CDER

Srikumaran Melethil, Law and Science Consulting

Stephanie Philbin, Goodwin Procter LLP

Alex Stack, Gilbert's LLP

Sarah Zagata Vasani, King & Spalding LLP

Rend Al-Mondhiry, Council for Responsible Nutrition
Vice Chair

Executive Committee

Geoffrey M. Levitt, Pfizer, Inc.
Chair

Elizabeth H. Anderson, Personal Care Products Council
Vice Chair

Minnie V. Baylor-Henry, JD, Johnson & Johnson
Immediate Past Chair

Jeffrey N. Gibbs, Hyman, Phelps & McNamara, P.C.
Secretary and General Counsel

Patricia B. Shrader, Medtronic, Inc.
Treasurer

Susan C. Winckler, RPh, JD, FDLI
President & CEO

Finance Committee


The purpose of the Finance Committee is to ensure the responsible financial operations of FDLI. The Committee provides on-going oversight of the financial operations and investment policies of FDLI to ensure sound financial management. The Committee also advises the Board on the direction and control of financial matters. The Committee also ensures that the Board is well informed about the Institute's finances.

Don L. Bell, II, National Association of Chain Drug Stores

David M. Fox, Hogan Lovells LLP

Madeleine M. McDonough, Shook, Hardy & Bacon L.L.P.

Patrick Ronan, Greenleaf Health LLC

Patricia B. Shrader, Medtronic, Inc.
Chair

Erika F. Lietzan, Covington & Burling LLP
Board Liaison

Food and Dietary Supplements Committee


The Food and Dietary Supplements Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the food and dietary supplement industries. The Committee advises staff on the appropriateness of conferences and publications relating to foods and dietary supplements by reviewing and commenting on proposals.

Steven H. Armstrong, Campbell Soup Company

Ann M. Boeckman, Kraft Foods Global

Cory Carter, Roll International Corporation

Benjamin L. England, FDAImports.com, LLC

Neal D. Fortin, Michigan State University

David A. Frumkin, Life Sciences Research Organization, Inc.

James C. Griffiths, PhD, U.S. Pharmacopeia

Martha A. Healey, Norton Rose LLP

Stephen L. Lacey, Abbott Laboratories

Michael M. Landa, JD, FDA - CFSAN
Co-Chair

Rachel G. Lattimore, Arent Fox LLP

Nicholas J. Licato, PhD, Nexgen Pharma, Inc.

John M. Packman, The Coca-Cola Company
Co-Chair

Jordi Serratosa, PhD, FDA - OC

Edward A. Steele, EAS Consulting Group, LLC

Ashish R. Talati, Amin Talati LLC

Peter E. Tamborski, Sugar Creek Packing Company

Ivan J. Wasserman, Manatt, Phelps & Phillips, LLP

Medical Devices Committee

The Medical Devices Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the Medical Devices industries. The Committee advises staff on the appropriateness of conferences and publications relating to medical devices by reviewing and commenting on proposals.

Jennifer L. Bragg, Skadden, Arps, Slate, Meagher & Flom LLP

David E. Chadwick, PhD, Cook Group Incorporated

Philip R. Desjardins, FDA - CDRH
Co-Chair

Andrew C. Fish, AdvaMed

Mark A. Heller, Goodwin Procter LLP

Sandra C. Kalter, Medtronic, Inc.

Konstantinos Makrodimitris, PhD, MSc, Sole Practitioner

Elaine C. Messa, RAC, Becker & Associates Consulting, Inc.

Nahed Mohsen, PhD, Exponent, Inc.

Patrick C. O'Brien, PharmD, Holland & Knight LLP

Neil F. O'Flaherty, Olsson Frank Weeda Terman Matz PC

Suzan Onel, K&L Gates LLP

Stacy L. Taylor, DLA Piper LLP US

Bradley M. Thompson, Epstein Becker & Green, P.C.
Co-Chair

Jesse A. Witten, Drinker Biddle & Reath LLP

Tobacco Committee

The Tobacco Committee advises FDLI staff in formulating and implementing policies and strategies relating to programs and publications about law, regulation and policy affecting tobacco products. Duties and Responsibilities include advising staff on the appropriateness of conferences and publications relating to this topic area by suggesting topics and reviewing and commenting on proposals.

James M. Solyst, MS, ENVIRON International Corp.

Joan Z. Bernstein, Kelley Drye & Warren LLP

Barbara A. Binzak, PhD, JD, Buchanan Ingersoll & Rooney PC

Beverly I. Chernaik, FDA - CTP
Chair

David B. Clissold, Hyman, Phelps & McNamara, P.C.

Farrell Delman, Tobacco Merchants Association

Stacy L. Ehrlich, Kleinfeld, Kaplan & Becker, LLP

Mark S. Frankel, PhD, American Association for the Advancement of Science
Chair

William A. McGrath, Wiley Rein LLP

Mitchell A. Neuhauser, RAI Services Company

Mitchell R. Zeller, Pinney Associates, Inc.

Allison M. Zieve, JD, Public Citizen Litigation Group

 

top bar

Copyright © 2012, The Food and Drug Law Institute